Tactile Systems Technology Inc (Tactile Medical) develops, manufactures, markets, and distributes innovative medical devices for the treatment of chronic vascular diseases at home.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company’s R&D intended to develop the innovation and advanced products for the customers in area of chronic disease, especially lymphedema, cancer-related lymphedema, chronic venous insufficiency, bronchiectasis and other chronic respiratory conditions. It’s development activities includes the scientists, clinical monitors and project managers with expertise in pneumatics, electronics, garment design, embedded software, mechanical design, sensors, manufacturing technologies and clinical trial management. It focuses to provide the increasing efficacy, enhancing design for ease-of-use, improving clinical functionality and lower production costs of its solutions. The company also aims on the competitors’ products. In FY2022, the company spend on the research and development of US$7.1 million which is 2.9% of the company’s total revenue. The company owns the 188 issued patents over the world including 62 issued US patents. It also consists of 30 pending patent applications in which 9 were pending patent applications in the United States. Its owns US patents between 2023 to 2040.